Iron overload signature in chrysotile-induced malignant mesothelioma

Journal of Pathology

Volumn 228, Issue 3, 2012, Pages 366-377

  Jiang, Li ^a   Akatsuka, Shinya ^a   Nagai, Hirotaka ^a,b   Chew, Shan Hwu ^a   Ohara, Hiroki ^a,b   Okazaki, Yasumasa ^a   Yamashita, Yoriko ^a   Yoshikawa, Yutaka ^c   Yasui, Hiroyuki ^c   Ikuta, Katsuya ^d   Sasaki, Katsunori ^d   Kohgo, Yutaka ^d   Hirano, Seishiro ^e   Shinohara, Yasushi ^f   Kohyama, Norihiko ^g   Takahashi, Takashi ^a   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^f NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

^g TOYO UNIVERSITY   (Japan)

Author keywords

ARF; array based comparative genomic hybridization; asbestos; CDKN2A 2B; iron; malignant mesothelioma

Indexed keywords

AMOSITE; ARF PROTEIN; CHRYSOTILE; CROCIDOLITE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FERRITIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR HAND1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA HYBRIDIZATION; GENE DELETION; HISTOLOGY; IRON OVERLOAD; MALE; MALIGNANT MESOTHELIOMA; MUTATION; NONHUMAN; PERITONEAL CAVITY; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ASBESTOS, SERPENTINE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; HOMEODOMAIN PROTEINS; IRON; IRON OVERLOAD; LUNG NEOPLASMS; MALE; MESOTHELIOMA; NITRILOTRIACETIC ACID; PERITONEAL NEOPLASMS; RATS; RATS, INBRED BN; RATS, INBRED F344; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867576196     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4075     Document Type: Article

References (49)

1. IARC, World Health Organization. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens; Part C: Arsenic, Metals, Fibres, and Dusts. IARC: Lyon, 2012; 219-309.
2. Roggli VL, Oury TD, Sporn TA, (eds). Pathology of Asbestos-Associated Diseases (2nd edn). Springer Verlag: New York, 2004.
3. Robinson B, Musk A, Lake R,. Malignant mesothelioma. Lancet 2005; 366: 397-408.
4. Robinson B, Lake R,. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-1603.
5. Alberg AJ, Ford JG, Samet JM,. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 29S-55S.
6. Editorials this week: asbestos scandal (16 December 2010). Nature 2010; 468: 868.
7. Smith AH, Wright CC,. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med 1996; 30: 252-266.
8. 79 Kubota workers killed by asbestos over 26 years. The Daily Yomiuri. The Yomiuri Shimbun: Japan; 30 June 2005.
9. Greenberg M,. The defence of chrysotile, 1912-2007. Int J Occup Environ Health 2008; 14: 57-66.
10. Hardy JA, Aust AE,. Iron in asbestos chemistry and carcinogenicity. Chem Rev 1995; 95: 97-118.
11. Wagner JC, Berry G, Timbrell V,. Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer 1973; 28: 173-185.
12. Jiang L, Nagai H, Ohara H, et al., Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 2008; 99: 2142-2151.
13. Nagai H, Okazaki Y, Chew SH, et al., Diameter of multi-walled carbon nanotubes is a critical factor in mesothelial injury and subsequent carcinogenesis. Proc Natl Acad Sci U S A 2011; 108: E1330-E1338.
14. Okada S, Hamazaki S, Toyokuni S, et al., Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. Br J Cancer 1989; 60: 708-711.
15. Hu Q, Akatsuka S, Yamashita Y, et al., Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab Invest 2010; 90: 360-373.
16. Jiang L, Yamashita Y, Toyokuni S,. A novel method for efficient collection of normal mesothelial cells in vivo. J Clin Biochem Nutr 2010; 46: 265-268.
17. Toyokuni S, Tanaka T, Hattori Y, et al., Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-374.
18. Shirase T, Mori K, Okazaki Y, et al., Suppression of SLC11A2 expression is essential to maintain duodenal integrity during dietary iron overload. Am J Pathol 2010; 177: 677-685.
19. Toyokuni S, Kawaguchi W, Akatsuka S, et al., Intermittent microwave irradiation facilitates antigen-antibody reaction in western blot analysis. Pathol Int 2003; 53: 259-261.
20. Hagiwara Y, Hamada Y, Kuwahara M, et al., Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma. Cancer Sci 2008; 99: 666-670.
21. Sasaki K, Ikuta K, Tanaka H, et al., Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination. Mol Med Rep 2011; 4: 913-918.
22. Mottola HA,. Nitrilotriacetic acid as a chelating agent: applications, toxicology, and bio-environmental impact. Toxicol Environ Chem Rev 1974; 71: 99-161.
23. Anderson RL, Bishop WE, Campbell RL,. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol 1985; 15: 1-102.
24. Toyokuni S,. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553-566.
25. Toyokuni S,. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009; 100: 9-16.
26. Toyokuni S, Sagripanti JL,. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 1992; 47: 241-248.
27. Toyokuni S, Okada S, Hamazaki S, et al., Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate- induced renal lipid peroxidation in ddY mice. Cancer Res 1990; 50: 5574-5580.
28. Dunn L, Rahmanto Y, Richardson D,. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007; 17: 93-100.
29. Cheng L, Zhou Z, Flesken-Nikitin A, et al., Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency. Oncogene 2010; 29: 5700-5711.
30. Lin YF, Tsai WP, Liu HG, et al., Intracellular beta-tubulin/ chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors. Cancer Res 2009; 69: 6879-6888.
31. Lee HS, Park MH, Yang SJ, et al., Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci 2007; 80: 690-698.
32. Stanton MF, Layard M, Tegeris A, et al., Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 1981; 67: 965-975.
33. Donaldson K, Aitken R, Tran L, et al., Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006; 92: 5-22.
34. Husain AN, Colby TV, Ordonez NG, et al., Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133: 1317-1331.
35. Shiomi K, Miyamoto H, Segawa T, et al., Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients. Cancer Sci 2006; 97: 928-932.
36. Hassan R, Remaley AT, Sampson ML, et al., Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006; 12: 447-453.
37. Nagai H, Ishihara T, Lee W-H, et al., Asbestos surface provides a niche for oxidative modification. Cancer Sci 2012; 102: 2118-2125.
38. Gazzano E, Turci F, Foresti E, et al., Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. Chem Res Toxicol 2007; 20: 380-387.
39. Toyokuni S,. Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr 2011; 48: 46-49.
40. Toyokuni S,. Iron as a target of chemoprevention for longevity in humans. Free Radic Res 2011; 45: 906-917.
41. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999; 18: 3793-3797.
42. Xio S, Li D, Vijg J, et al., Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 1995; 11: 511-515.
43. Sekido Y,. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Pathol Int 2011; 61: 331-344.
44. Jean D, Thomas E, Manie E, et al., Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol 2011; 178: 881-894.
45. Foster SA, Wong DJ, Barrett MT, et al., Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 1998; 18: 1793-1801.
46. Miceli MH, Dong L, Grazziutti ML, et al., Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transpl 2006; 37: 857-864.
47. Miyama K, Yamada G, Yamamoto T, et al., A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol 1999; 208: 123-133.
48. Firulli A, McFadden D, Lin Q, et al., Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nature Genet 1998; 18: 266-270.
49. Khoo M, McQuade L, Smith M, et al., Growth and differentiation of embryoid bodies derived from human embryonic stem cells: effect of glucose and basic fibroblast growth factor. Biol Reprod 2005; 73: 1147-1156.